DAX24.853 -1,1%Est506.238 -1,2%MSCI World4.343 -0,1%Top 10 Crypto8,1000 -4,3%Nas26.167 -1,3%Bitcoin54.656 -2,4%Euro1,1408 -0,2%Öl77,46 -0,9%Gold4.128 -1,5%

PTC Therapeutics Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

68,28 EUR -2,54 EUR -3,59 %

12:01:33

STU

79,90 USD +0,98 USD +1,24 %

nachbörslich10:04:14

BTT

PTC Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Smartphone

Marktkap.5,74 Mrd. EUR

KGV9,76Div. Rendite0,00%

WKNA1W0MW

ISINUS69366J2006

SymbolPTCT

PTC Therapeutics Aktien News

Sortieren:Datum Meistgelesen

26.10.23PR NewswirePTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results

19.10.23PR NewswirePTC Therapeutics Announces Evrysdi® Royalty Agreement with Royalty Pharma for Up To $1.5 Billion

16.10.23PR NewswirePTC Therapeutics to Host Conference Call to Discuss Third Quarter 2023 Financial Results 

28.09.23PR NewswirePTC Announces Further Strategic Prioritization and Associated Reduction in Workforce

21.09.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

15.09.23PR NewswireCHMP Delivers Opinion on Translarna™ for Conversion to Full Authorization

07.09.23PR NewswirePTC Therapeutics' 2023 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community

07.09.23PR NewswireAustralian Patient Advocacy Organization Named a Recipient of PTC Therapeutics' 2023 STRIVE™ Award for Duchenne Muscular Dystrophy

30.08.23PR NewswirePTC Therapeutics to Participate at Upcoming Investor Conferences

28.08.23PR NewswirePTC Therapeutics to Present Recent Data for Sepiapterin at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium

03.08.23PR NewswirePTC Therapeutics Provides Corporate Update and Reports Second Quarter Financial Results

21.07.23PR NewswireCHMP Recommends Evrysdi® for Babies Under Two Months Old with Spinal Muscular Atrophy

20.07.23PR NewswirePTC Therapeutics to Host Conference Call to Discuss Second Quarter 2023 Financial Results

19.07.23PR NewswirePTC Therapeutics Co-Founder Allan Jacobson, Ph.D., Awarded 2023 Gruber Genetics Prize

18.07.23PR NewswirePTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

17.07.23PR NewswirePTC Therapeutics Appoints Experienced Healthcare Finance Strategist Pierre Gravier as Chief Financial Officer

11.07.23PR NewswirePTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and Sepiapterin

03.07.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

29.06.23PR NewswirePTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone for the Treatment of Mitochondrial Disease Associated Seizures

24.06.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

PTC Therapeutics News

PTC Therapeutics News: auf dieser Seite finden Sie alle PTC Therapeutics News und Nachrichten zur PTC Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch PTC Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um PTC Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.